Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru

Patricio Escalante, S. Ramaswamy, H. Sanabria, H. Soini, X. Pan, L. Asencio, O. Valiente-Castillo, J. M. Musser

Research output: Contribution to journalArticle

Abstract

Purpose: There is a need for genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates recovered from patients living in areas with a high prevalence of primary and secondary drug resistace to first line antituberculous agents. We investigated the molecular genetics of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) strains recovered in a Latin American country. Methods: We studied twenty-nine epidemiologically unrelated and mostly MDR-TB strains from Peruvian patients. We determined the antimicrobial agent susceptibility pattern, major genetic group designation, IS6110 fingerprinting, spoligotyping, and automated DNA sequencing of regions of the katG, rpoB, emoB, gyrA, and pncA genes with mutations commonly associated with drug resistance. Results: Nineteen isolates were found to be multidrug-resistant by susceptibility testing. IS6110 typing showed that virtually all isolates were unique and therefore had independently acquired drug resistance. Seventy-nine percent of isoniazid-resistant strains had a Ser315Thr amino acid change in KatG. Ninety-five percent of rifampin-resistant isolates had amino acid replacements in the rifampin-resistance determining region of RpoB. Six of eleven ethambutol-resistant strains had EmbB alterations. Eleven pyrazinamide-resistant strains had distinct mutations in pncA. Conclusions: Virtually all organisms evolved drug resistance independently. The types of drug resistance-associated mutations identified were very similar to changes occurring in isolates from other areas of the world. Clinical Implications: Nucleotide sequence-based strategies for rapid detection of drug resistance-conferring mutants will be applicable to organisms recovered in Peru, and potentially other areas of Latin America.

Original languageEnglish (US)
JournalChest
Volume114
Issue number4 SUPPL.
StatePublished - Oct 1998
Externally publishedYes

Fingerprint

Multidrug-Resistant Tuberculosis
Peru
Mycobacterium tuberculosis
Drug Resistance
Rifampin
Mutation
Pyrazinamide
Amino Acids
Ethambutol
Latin America
Isoniazid
Anti-Infective Agents
DNA Sequence Analysis
Molecular Biology
Pharmaceutical Preparations
Genes

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Escalante, P., Ramaswamy, S., Sanabria, H., Soini, H., Pan, X., Asencio, L., ... Musser, J. M. (1998). Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Chest, 114(4 SUPPL.).

Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. / Escalante, Patricio; Ramaswamy, S.; Sanabria, H.; Soini, H.; Pan, X.; Asencio, L.; Valiente-Castillo, O.; Musser, J. M.

In: Chest, Vol. 114, No. 4 SUPPL., 10.1998.

Research output: Contribution to journalArticle

Escalante, P, Ramaswamy, S, Sanabria, H, Soini, H, Pan, X, Asencio, L, Valiente-Castillo, O & Musser, JM 1998, 'Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru', Chest, vol. 114, no. 4 SUPPL..
Escalante P, Ramaswamy S, Sanabria H, Soini H, Pan X, Asencio L et al. Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Chest. 1998 Oct;114(4 SUPPL.).
Escalante, Patricio ; Ramaswamy, S. ; Sanabria, H. ; Soini, H. ; Pan, X. ; Asencio, L. ; Valiente-Castillo, O. ; Musser, J. M. / Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. In: Chest. 1998 ; Vol. 114, No. 4 SUPPL.
@article{a20b80116f4448ff913d9527739910b1,
title = "Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru",
abstract = "Purpose: There is a need for genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates recovered from patients living in areas with a high prevalence of primary and secondary drug resistace to first line antituberculous agents. We investigated the molecular genetics of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) strains recovered in a Latin American country. Methods: We studied twenty-nine epidemiologically unrelated and mostly MDR-TB strains from Peruvian patients. We determined the antimicrobial agent susceptibility pattern, major genetic group designation, IS6110 fingerprinting, spoligotyping, and automated DNA sequencing of regions of the katG, rpoB, emoB, gyrA, and pncA genes with mutations commonly associated with drug resistance. Results: Nineteen isolates were found to be multidrug-resistant by susceptibility testing. IS6110 typing showed that virtually all isolates were unique and therefore had independently acquired drug resistance. Seventy-nine percent of isoniazid-resistant strains had a Ser315Thr amino acid change in KatG. Ninety-five percent of rifampin-resistant isolates had amino acid replacements in the rifampin-resistance determining region of RpoB. Six of eleven ethambutol-resistant strains had EmbB alterations. Eleven pyrazinamide-resistant strains had distinct mutations in pncA. Conclusions: Virtually all organisms evolved drug resistance independently. The types of drug resistance-associated mutations identified were very similar to changes occurring in isolates from other areas of the world. Clinical Implications: Nucleotide sequence-based strategies for rapid detection of drug resistance-conferring mutants will be applicable to organisms recovered in Peru, and potentially other areas of Latin America.",
author = "Patricio Escalante and S. Ramaswamy and H. Sanabria and H. Soini and X. Pan and L. Asencio and O. Valiente-Castillo and Musser, {J. M.}",
year = "1998",
month = "10",
language = "English (US)",
volume = "114",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru

AU - Escalante, Patricio

AU - Ramaswamy, S.

AU - Sanabria, H.

AU - Soini, H.

AU - Pan, X.

AU - Asencio, L.

AU - Valiente-Castillo, O.

AU - Musser, J. M.

PY - 1998/10

Y1 - 1998/10

N2 - Purpose: There is a need for genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates recovered from patients living in areas with a high prevalence of primary and secondary drug resistace to first line antituberculous agents. We investigated the molecular genetics of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) strains recovered in a Latin American country. Methods: We studied twenty-nine epidemiologically unrelated and mostly MDR-TB strains from Peruvian patients. We determined the antimicrobial agent susceptibility pattern, major genetic group designation, IS6110 fingerprinting, spoligotyping, and automated DNA sequencing of regions of the katG, rpoB, emoB, gyrA, and pncA genes with mutations commonly associated with drug resistance. Results: Nineteen isolates were found to be multidrug-resistant by susceptibility testing. IS6110 typing showed that virtually all isolates were unique and therefore had independently acquired drug resistance. Seventy-nine percent of isoniazid-resistant strains had a Ser315Thr amino acid change in KatG. Ninety-five percent of rifampin-resistant isolates had amino acid replacements in the rifampin-resistance determining region of RpoB. Six of eleven ethambutol-resistant strains had EmbB alterations. Eleven pyrazinamide-resistant strains had distinct mutations in pncA. Conclusions: Virtually all organisms evolved drug resistance independently. The types of drug resistance-associated mutations identified were very similar to changes occurring in isolates from other areas of the world. Clinical Implications: Nucleotide sequence-based strategies for rapid detection of drug resistance-conferring mutants will be applicable to organisms recovered in Peru, and potentially other areas of Latin America.

AB - Purpose: There is a need for genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates recovered from patients living in areas with a high prevalence of primary and secondary drug resistace to first line antituberculous agents. We investigated the molecular genetics of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) strains recovered in a Latin American country. Methods: We studied twenty-nine epidemiologically unrelated and mostly MDR-TB strains from Peruvian patients. We determined the antimicrobial agent susceptibility pattern, major genetic group designation, IS6110 fingerprinting, spoligotyping, and automated DNA sequencing of regions of the katG, rpoB, emoB, gyrA, and pncA genes with mutations commonly associated with drug resistance. Results: Nineteen isolates were found to be multidrug-resistant by susceptibility testing. IS6110 typing showed that virtually all isolates were unique and therefore had independently acquired drug resistance. Seventy-nine percent of isoniazid-resistant strains had a Ser315Thr amino acid change in KatG. Ninety-five percent of rifampin-resistant isolates had amino acid replacements in the rifampin-resistance determining region of RpoB. Six of eleven ethambutol-resistant strains had EmbB alterations. Eleven pyrazinamide-resistant strains had distinct mutations in pncA. Conclusions: Virtually all organisms evolved drug resistance independently. The types of drug resistance-associated mutations identified were very similar to changes occurring in isolates from other areas of the world. Clinical Implications: Nucleotide sequence-based strategies for rapid detection of drug resistance-conferring mutants will be applicable to organisms recovered in Peru, and potentially other areas of Latin America.

UR - http://www.scopus.com/inward/record.url?scp=33750267694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750267694&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750267694

VL - 114

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4 SUPPL.

ER -